Milder stem cell transplant offers hope for kids with rare immune diseases
NCT ID NCT01821781
First seen Feb 26, 2026 · Last updated May 13, 2026 · Updated 10 times
Summary
This study tests a stem cell transplant for children and young adults up to age 28 with serious immune system disorders. The goal is to replace their faulty immune cells with healthy donor cells using a milder chemotherapy-like preparation to reduce side effects. The study tracks whether the donor cells successfully engraft and how well patients recover.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRANULOMATOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.